中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2014年
17期
10-11,12
,共3页
陈锡创%洪远%冯锦华%糜菁熠%尤晓红
陳錫創%洪遠%馮錦華%糜菁熠%尤曉紅
진석창%홍원%풍금화%미정습%우효홍
头孢唑林钠%丹皮酚磺酸钠%配伍稳定性%高效液相色谱法
頭孢唑林鈉%丹皮酚磺痠鈉%配伍穩定性%高效液相色譜法
두포서림납%단피분광산납%배오은정성%고효액상색보법
cefazolin sodium reaction%sodium paeonol sulfonate%compatible stability%HPLC
目的:观察注射用头孢唑林钠与丹皮酚磺酸钠注射液在0.9%氯化钠注射液中的配伍稳定性。方法模拟临床使用条件,用高效液相色谱法测定头孢唑林钠与丹皮酚磺酸钠配伍后6 h内的相对百分含量,并观察其外观、不溶性微粒数及pH变化。结果头孢唑林钠与丹皮酚磺酸钠配伍后,在室温下放置6 h,配伍液的外观、不溶性微粒数、pH及含量均无明显变化。结论注射用头孢唑林钠与丹皮酚磺酸钠注射液在0.9%氯化钠注射液中配伍后,室温下6 h内可使用。
目的:觀察註射用頭孢唑林鈉與丹皮酚磺痠鈉註射液在0.9%氯化鈉註射液中的配伍穩定性。方法模擬臨床使用條件,用高效液相色譜法測定頭孢唑林鈉與丹皮酚磺痠鈉配伍後6 h內的相對百分含量,併觀察其外觀、不溶性微粒數及pH變化。結果頭孢唑林鈉與丹皮酚磺痠鈉配伍後,在室溫下放置6 h,配伍液的外觀、不溶性微粒數、pH及含量均無明顯變化。結論註射用頭孢唑林鈉與丹皮酚磺痠鈉註射液在0.9%氯化鈉註射液中配伍後,室溫下6 h內可使用。
목적:관찰주사용두포서림납여단피분광산납주사액재0.9%록화납주사액중적배오은정성。방법모의림상사용조건,용고효액상색보법측정두포서림납여단피분광산납배오후6 h내적상대백분함량,병관찰기외관、불용성미립수급pH변화。결과두포서림납여단피분광산납배오후,재실온하방치6 h,배오액적외관、불용성미립수、pH급함량균무명현변화。결론주사용두포서림납여단피분광산납주사액재0.9%록화납주사액중배오후,실온하6 h내가사용。
Objective To study the compatible stability of Cefazolin Sodium Injection with Sodium Paeonol Sulfonate Injection in 0. 9%Sodium Chloride Injection. Methods The high performance liquid chromatography ( HPLC ) was adopted to detect the relative percentage content of cefazolin sodium and sodium paeonol sulfonate within 6 h in stimulated clinical conditions. The appearance of the solution, pH value and the number of insoluble particles were observed. Results There were no evident changes in the appearance, pH value, number of insoluble particles and the content of cefazolin sodium and sodium paeonol sulfonate of the compatible solution within 6 h at room temperature. Conclusion The compatible solution of Cefazolin Sodium Injection with Sodium Paeonol Sulfonate Injection in 0. 9%Sodium Chloride Injection can be used within 6 h at room temperature .